|
|
|
|
|
|
|
|
Note: warning on stats
"Results: Overall, 36 OCR patients were enrolled. The majority of the patients (>80%) were classified as platinum resistant.....
Prospective phase III trials are warranted to evaluate the benefit and efficacy in heavily pre-treated patients with OCR."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.